Shownotes
In this episode of Hybrid Healing Hour, we sit down with Dr. Michael Hafran, Regional Medical Director of Flourish Research in Boca Raton, for an in-depth conversation on the future of cardiovascular medicine: gene editing for high cholesterol.Dr. Hafran takes us inside the groundbreaking VERVE-102 clinical trial, developed by Verve Therapeutics, which aims to transform how we treat familial hypercholesterolemia (FH) and severe LDL elevation. Rather than relying solely on lifelong medications to manage cholesterol levels, this investigational therapy explores the possibility of rewriting…
Website: player.amperwavepodcasting.com

